论文部分内容阅读
目的:观察研究肝硬化患者通过口服益生菌的制剂后对血浆内毒素以及肝功能指标变化以及产生的影响。方法:有针对性进行培养和计数5种具有代表性的肠道菌群,研究组的25例给予常规治疗,治疗组的25例则在常规治疗的基础上给予益生菌治疗,疗程为10天。观察研究两组患者的在治疗前后的血浆内毒素水平以及肝功能指数变化。结果:观察发现治疗组的患者治疗效果要好于研究组。结论:研究发现益生菌可以有效改善肝硬化患者的肠道菌群失调,血毒素水平和肝功能指数都正常化,效果明显[1]。
OBJECTIVE: To observe the effects of oral probiotics on the changes of endotoxin and liver function in patients with liver cirrhosis. Methods: Five kinds of representative gut microbiota were cultured and counted. 25 cases in the study group were given routine treatment. The 25 cases in the treatment group were treated with probiotics on the basis of routine treatment for 10 days . Observe the changes of plasma endotoxin level and liver function index in two groups before and after treatment. Results: The observation showed that the treatment group patients treated better than the study group. Conclusion: The study found that probiotics can effectively improve the intestinal flora of patients with liver cirrhosis, blood toxin levels and liver function index are normalized, the effect is obvious [1].